New Weight Loss Drug Produces 25% Average Weight Loss in 18 Months. Some Participants Had to STOP Because They Lost Too Much

 Written by 

Julien Raby

 Last updated on 


In a recent YouTube video, a physician trained in obesity medicine called retatrutide “one of the biggest pharmacological advances in obesity treatment that we have ever seen.”

Headline results from the new TRIUMPH 1 trial sound almost too big to believe.

new-weight-loss-drug-outperforms-surgery
  • Save

Some participants actually cut back or quit because they had lost too much weight.

Another question worries the doctor even more: what was all that lost weight made of?

Here is what the data shows, and the two habits that may matter most.

Up to 25% Body Weight Loss, Explained

At the highest dose, participants lost an average of 25% of body weight over 80 weeks. Published in the New England Journal of Medicine, the phase 3 trial enrolled 2,339 adults with obesity but without diabetes across 131 sites in 11 countries.

Build Strength and Conditioning With One Simple Tool
FULL-BODY TRAINING

If you want something simple that actually works, this is one of the most effective tools I’ve used to build strength, conditioning, and endurance without needing a full gym setup.

  • Full-body training with one weight using swings, squats, and presses
  • Solid cast iron build that feels stable and lasts for years
  • Comfortable grip that makes high-rep workouts easier to handle

We have never never seen weight loss like this before with a drug.

Participants averaged 248 pounds with a BMI near 40. A 25% drop works out to roughly 62 pounds, landing people near 186.

Results by Dose

  • 4 mg: roughly 17% to 19% weight loss
  • 9 mg: about 23.7% to 25.9%
  • 12 mg: 25% to 28%
  • Placebo: around 2.2% to 4%

Placebo results matter here. Lifestyle changes alone rarely get people far, and the physician noted that reaching and sustaining even 5% or 10% is difficult in real-world clinics.

How Many People Hit Big Milestones on 12 mg?

  • 80% lost at least 15%
  • 67% lost at least 20%
  • 53% lost at least 25%
  • 37% lost at least 30%
  • 21% lost at least 35%

More than half of this group dropped from a BMI of 40 to below 30. About one in four fell under 25, which is normal-weight territory.

An extension phase reported roughly 30% average loss at 104 weeks. The 80-week figure, in the physician’s view, “may eventually understate the max potential.”

How Retatrutide Stacks Up Against Semaglutide and Tirzepatide

Semaglutide produced about 15% average loss in the STEP 1 trial. Tirzepatide reached roughly 21% at its top dose in SURMOUNT 1.

Retatrutide is a triple agonist, targeting GLP-1, GIP and glucagon receptors. Semaglutide hits one pathway, tirzepatide two, and retatrutide three.

Build Strength and Conditioning With One Simple Tool
FULL-BODY TRAINING

If you want something simple that actually works, this is one of the most effective tools I’ve used to build strength, conditioning, and endurance without needing a full gym setup.

  • Full-body training with one weight using swings, squats, and presses
  • Solid cast iron build that feels stable and lasts for years
  • Comfortable grip that makes high-rep workouts easier to handle
  • GLP-1: acts on the brain to curb appetite, slows stomach emptying and boosts insulin secretion
  • GIP: complements GLP-1 in brain and pancreas
  • Glucagon: a fasting hormone that also appears to increase fat oxidation and mobilization

Why add glucagon? Preclinical work in obese mice suggested it drives extra weight loss through higher energy expenditure.

This is a big but, and none of this is proven in humans, but that is the hypothesis for the greater weight loss.

Another caveat: no head-to-head trial yet pits retatrutide against tirzepatide. Precedent exists, though. SURMOUNT 5 later confirmed tirzepatide’s edge over semaglutide, about 20% versus 14% at 72 weeks.

Beyond the Scale: Health Markers Moved Too

Weight was never the only story. At 12 mg, several measures shifted dramatically:

  • Waist circumference fell by 8.5 inches
  • Systolic blood pressure dropped about 10 mm Hg
  • Triglycerides declined 38%
  • Fasting insulin plunged 55%
  • CRP, an inflammation marker, fell 63%

Some benefits may stem from the drug itself rather than weight loss alone. Still, the physician stressed that “losing 25% of body weight itself profoundly changes physiology.”

Built-in substudies looked at 547 people with knee osteoarthritis and 243 with obstructive sleep apnea. Knee pain scores improved substantially, apneas per hour dropped markedly, and most participants with prediabetes reached normal glucose levels.

The value of these medications isn’t simply fitting into smaller jeans.

The Muscle Question Nobody Can Ignore

TRIUMPH 1 did not provide a detailed body composition analysis. For a physician who cares “mostly about muscle,” that gap stings.

Build Strength and Conditioning With One Simple Tool
FULL-BODY TRAINING

If you want something simple that actually works, this is one of the most effective tools I’ve used to build strength, conditioning, and endurance without needing a full gym setup.

  • Full-body training with one weight using swings, squats, and presses
  • Solid cast iron build that feels stable and lasts for years
  • Comfortable grip that makes high-rep workouts easier to handle

Earlier phase 2 DEXA data offers clues. Lean mass fell by up to 12.5%, roughly 14 pounds, at the 8 mg dose, which works out to about 30% to 40% of total weight lost.

Context matters, because that substudy involved people with type 2 diabetes, not the obesity-without-diabetes group in TRIUMPH 1. Treat the figures as a rough guide rather than a final answer.

Why It May Not Be Alarming

Reviewers concluded that relative lean mass loss stayed within the range seen with other obesity drugs. Dieting in general typically sheds 20% to 40% of weight as fat-free mass, which includes organs and bone, not just muscle.

None of these drugs have magical muscle-preserving effects, and neither does plain old dieting.

Two Levers That Protect Muscle

Training and protein, according to the physician, are “going to be the biggest preventative factor” against lean mass loss. Evidence she cited points to two specific targets:

  • Resistance training two or three times weekly
  • Protein at about 1.2 to 1.6 grams per kilogram of body weight daily

One example: Longland and colleagues put recreationally active young men on a 40% energy deficit for four weeks, training six days weekly. Both protein groups (1.2 or 2.4 g/kg) gained fat-free mass, though the higher-protein group gained significantly more while also losing more fat.

Caveat: young, active men are not people with severe obesity on a powerful injectable. Meta-analysis data she referenced suggests resistance training alone can prevent most diet-related lean mass loss, but nobody has tested this combination alongside retatrutide.

Build Strength and Conditioning With One Simple Tool
FULL-BODY TRAINING

If you want something simple that actually works, this is one of the most effective tools I’ve used to build strength, conditioning, and endurance without needing a full gym setup.

  • Full-body training with one weight using swings, squats, and presses
  • Solid cast iron build that feels stable and lasts for years
  • Comfortable grip that makes high-rep workouts easier to handle

If modern obesity medicine gives us an unprecedented ability to lose body weight, then our job becomes making the quality of that weight loss as good as possible.

Side Effects and the “Too Much Weight Loss” Surprise

Familiar gastrointestinal complaints dominated, mostly during dose escalation:

  • Nausea: 42%
  • Diarrhea: 32%
  • Constipation: 26%
  • Vomiting: 25%

Slowing the dose increase or lowering the dose often helps. Side effects remain probably the top reason people stop these drugs.

Then came the twist. At the highest dose, 5.3% discontinued because weight loss was considered excessive or already sufficient.

Losing too much weight too rapidly simply increases the risk that we are losing muscle as well.

Her takeaway: “More drug is not automatically better medicine.” Perhaps not everyone needs the top dose.

Is Retatrutide Available? Not Legitimately

Retatrutide remains investigational and not FDA-approved. Finishing a phase 3 trial is not the same as winning approval, which requires manufacturers to submit evidence showing benefits outweigh risks.

Social media sellers pitching “research chemical” versions are not offering a regulated medicine. Unapproved, she noted, “doesn’t mean that it doesn’t work,” yet approval exists for a reason.

Build Strength and Conditioning With One Simple Tool
FULL-BODY TRAINING

If you want something simple that actually works, this is one of the most effective tools I’ve used to build strength, conditioning, and endurance without needing a full gym setup.

  • Full-body training with one weight using swings, squats, and presses
  • Solid cast iron build that feels stable and lasts for years
  • Comfortable grip that makes high-rep workouts easier to handle

The Bigger Picture

A decade ago, 5% to 10% loss from medication counted as success. Semaglutide made 15% realistic, tirzepatide pushed toward 20%, and retatrutide now averages around 25%, with some people exceeding 35%.

Future questions will shift from can people lose enough weight? to how can muscle and bone be preserved while pairing treatment with nutrition and strength work. Her closing message was simple:

The goal was never weight loss. The goal has always been building stronger, more resilient, healthier humans.

Share via
Copy link